These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19252334)

  • 1. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negligible impact of birth on renal function and drug metabolism.
    Anderson BJ; Holford NHG
    Paediatr Anaesth; 2018 Nov; 28(11):1015-1021. PubMed ID: 30303265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
    Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
    Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population clinical pharmacology of children: modelling covariate effects.
    Anderson BJ; Allegaert K; Holford NH
    Eur J Pediatr; 2006 Dec; 165(12):819-29. PubMed ID: 16807729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Predictive Value of Glomerular Filtration Rate-Based Scaling of Pediatric Clearance and Doses for Drugs Eliminated by Glomerular Filtration with Varying Protein-Binding Properties.
    Cristea S; Krekels EHJ; Allegaert K; Knibbe CAJ
    Clin Pharmacokinet; 2020 Oct; 59(10):1291-1301. PubMed ID: 32314184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
    Morgan DJ; Bray KM
    Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a morphine maturation model for the prediction of morphine clearance in children: how accurate is the predictive performance of the model?
    Mahmood I
    Br J Clin Pharmacol; 2011 Jan; 71(1):88-94. PubMed ID: 21143504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007.
    McLeay SC; Morrish GA; Kirkpatrick CM; Green B
    Clin Pharmacokinet; 2012 May; 51(5):319-30. PubMed ID: 22439649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.
    Sinha J; Duffull SB; Green B; Al-Sallami HS
    Clin Pharmacokinet; 2020 Apr; 59(4):475-483. PubMed ID: 31583612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First dose in children: physiological insights into pharmacokinetic scaling approaches and their implications in paediatric drug development.
    Strougo A; Eissing T; Yassen A; Willmann S; Danhof M; Freijer J
    J Pharmacokinet Pharmacodyn; 2012 Apr; 39(2):195-203. PubMed ID: 22311388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism.
    Cerruti L; Bleyzac N; Tod M
    Clin Pharmacokinet; 2018 Jul; 57(7):831-841. PubMed ID: 28889370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of morphine clearance in the paediatric population : how accurate are the available pharmacokinetic models?
    Krekels EH; Tibboel D; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2012 Nov; 51(11):695-709. PubMed ID: 23018467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Drug Exposure in Critically Ill Encephalopathic Neonates Treated With Therapeutic Hypothermia Based on a Pooled Population Pharmacokinetic Analysis of Seven Drugs and Five Metabolites.
    Favié LMA; de Haan TR; Bijleveld YA; Rademaker CMA; Egberts TCG; Nuytemans DHGM; Mathôt RAA; Groenendaal F; Huitema ADR
    Clin Pharmacol Ther; 2020 Nov; 108(5):1098-1106. PubMed ID: 32463940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?
    Calvier EA; Krekels EH; Välitalo PA; Rostami-Hodjegan A; Tibboel D; Danhof M; Knibbe CA
    Clin Pharmacokinet; 2017 Mar; 56(3):273-285. PubMed ID: 27510367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic approach for the scaling of clearance in children.
    Edginton AN; Schmitt W; Voith B; Willmann S
    Clin Pharmacokinet; 2006; 45(7):683-704. PubMed ID: 16802850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
    Alcorn J; McNamara PJ
    Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug clearance in children: an evaluation of the predictive performance of several models.
    Mahmood I; Staschen CM; Goteti K
    AAPS J; 2014 Nov; 16(6):1334-43. PubMed ID: 25274608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages.
    Strougo A; Yassen A; Monnereau C; Danhof M; Freijer J
    J Clin Pharmacol; 2014 Sep; 54(9):1006-15. PubMed ID: 24676942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of morphine dose in humans.
    Holford NH; Ma SC; Anderson BJ
    Paediatr Anaesth; 2012 Mar; 22(3):209-22. PubMed ID: 22212108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.